Defence Therapeutics Stock Forecast

Sell candidate since Jun 15, 2026 Loss -6.32%

The Defence Therapeutics Inc stock price gained 2.34% on the last trading day (Monday, 22nd Jun 2026), rising from $0.339 to $0.347. During the last trading day the stock fluctuated 4.57% from a day low at $0.340 to a day high of $0.356. The price has fallen in 7 of the last 10 days and is down by -9.88% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 2 thousand more shares were traded than the day before. In total, 9 thousand shares were bought and sold for approximately $2.95 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -9.45% during the next 3 months and, with a 90% probability hold a price between $0.275 and $0.419 at the end of this 3-month period.

DTCFF Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, June 18, 2026, and so far it has risen 2.34%. Further rise is indicated until a new top pivot has been found. Defence Therapeutics Inc has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Defence Therapeutics Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.362 and $0.374. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Defence Therapeutics Inc stock

Defence Therapeutics Inc finds support from accumulated volume at $0.342 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0155 between high and low, or 4.57%. For the last week, the stock has had daily average volatility of 11.08%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (DTCFF) For The Upcoming Trading Day Of Tuesday 23rd

For the upcoming trading day on Tuesday, 23rd we expect Defence Therapeutics Inc to open at $0.347, and during the day (based on 14 day Average True Range), to move between $0.327 and $0.366, which gives a possible trading interval of +/-$0.0389 (+/-11.88%) up or down from last closing price. If Defence Therapeutics Inc takes out the full calculated possible swing range there will be an estimated 11.88% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.350 (0.98%) than the support at $0.342 (1.22%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Defence Therapeutics Inc stock A Buy?

Defence Therapeutics Inc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.237 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 23, 2026 - $0.347 ( 0.220%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk